Ensign Peak Advisors’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-340
| Closed | -$5.38K | – | 1708 |
|
|
2024
Q4 | $5.38K | Sell |
340
-71,400
| -100% | -$1.13M | ﹤0.01% | 1707 |
|
|
2024
Q3 | $4.17M | Hold |
71,740
| – | – | 0.01% | 691 |
|
|
2024
Q2 | $3.28M | Hold |
71,740
| – | – | 0.01% | 746 |
|
|
2024
Q1 | $4.75M | Buy |
+71,740
| New | +$4.75M | 0.01% | 642 |
|
|
2022
Q4 | – | Sell |
-2,380
| Closed | -$90K | – | 2012 |
|
|
2022
Q3 | $90K | Hold |
2,380
| – | – | ﹤0.01% | 2118 |
|
|
2022
Q2 | $66K | Hold |
2,380
| – | – | ﹤0.01% | 2036 |
|
|
2022
Q1 | $129K | Hold |
2,380
| – | – | ﹤0.01% | 1983 |
|
|
2021
Q4 | $139K | Buy |
+2,380
| New | +$139K | ﹤0.01% | 2004 |
|